Also known as: ERGO, EGT
Latest evidence update: 2022-02-01
Strongest in Consistency (85). Held back by Replication (55).
Solid mix of RCTs with some methodological gaps.
Good cross-study replication, some imprecision.
Tens of thousands of participants pooled across studies.
Studies agree on direction of effect.
Healthy mix of recent and established research.
No per-outcome numbers yet for this one. Each finding's direction and strength is shown in the research below.
Areas where research points to a consistent direction of effect. The strength of evidence is graded; the size of the effect is not quantified.
Recommended: 5-25mg daily
ProtocolEngine provides general health information based on published research. This is not medical advice. Consult a healthcare professional before starting any supplement or health protocol.
May support cognitive function and brain health through multiple protective mechanisms including antioxidant, anti-inflammatory, and neuroprotective effects
May help prevent age-related cognitive decline and neurodegenerative diseases through antioxidant, anti-inflammatory, and anti-aging properties
Improves ovarian reserve markers, including increased anti-müllerian hormone and estradiol levels, in women with diminished ovarian reserve
Improves quality of life, sleep quality, and reduces menstrual and perimenopausal symptoms in women with diminished ovarian reserve
Slightly reduces follicle-stimulating hormone levels in women with diminished ovarian reserve